Zobrazeno 1 - 10 of 423 pro vyhledávání: '"Dingley K"'
1
Akademický článek
1β-Hydroxydeoxycholic Acid as an Endogenous Biomarker in Human Plasma for Assessment of CYP3A Clinical Drug-Drug Interaction Potential.
Autor: Xue Y; Clinical Pharmacology, Pharmacometrics & Bioanalysis, Bristol-Myers Squibb, Princeton, New Jersey (Y.X., L.W., R.H., B.M., A.G., J.X.S.); Regeneron Pharmaceuticals Inc., Tarrytown, New York (M.C.); and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Princeton, New Jersey (K.D.) yongjun.xue@bms.com., Wang L; Clinical Pharmacology, Pharmacometrics & Bioanalysis, Bristol-Myers Squibb, Princeton, New Jersey (Y.X., L.W., R.H., B.M., A.G., J.X.S.); Regeneron Pharmaceuticals Inc., Tarrytown, New York (M.C.); and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Princeton, New Jersey (K.D.)., Huo R; Clinical Pharmacology, Pharmacometrics & Bioanalysis, Bristol-Myers Squibb, Princeton, New Jersey (Y.X., L.W., R.H., B.M., A.G., J.X.S.); Regeneron Pharmaceuticals Inc., Tarrytown, New York (M.C.); and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Princeton, New Jersey (K.D.)., Chen M; Clinical Pharmacology, Pharmacometrics & Bioanalysis, Bristol-Myers Squibb, Princeton, New Jersey (Y.X., L.W., R.H., B.M., A.G., J.X.S.); Regeneron Pharmaceuticals Inc., Tarrytown, New York (M.C.); and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Princeton, New Jersey (K.D.)., Melo B; Clinical Pharmacology, Pharmacometrics & Bioanalysis, Bristol-Myers Squibb, Princeton, New Jersey (Y.X., L.W., R.H., B.M., A.G., J.X.S.); Regeneron Pharmaceuticals Inc., Tarrytown, New York (M.C.); and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Princeton, New Jersey (K.D.)., Dingley K; Clinical Pharmacology, Pharmacometrics & Bioanalysis, Bristol-Myers Squibb, Princeton, New Jersey (Y.X., L.W., R.H., B.M., A.G., J.X.S.); Regeneron Pharmaceuticals Inc., Tarrytown, New York (M.C.); and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Princeton, New Jersey (K.D.)., Gaudy A; Clinical Pharmacology, Pharmacometrics & Bioanalysis, Bristol-Myers Squibb, Princeton, New Jersey (Y.X., L.W., R.H., B.M., A.G., J.X.S.); Regeneron Pharmaceuticals Inc., Tarrytown, New York (M.C.); and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Princeton, New Jersey (K.D.)., Shen JX; Clinical Pharmacology, Pharmacometrics & Bioanalysis, Bristol-Myers Squibb, Princeton, New Jersey (Y.X., L.W., R.H., B.M., A.G., J.X.S.); Regeneron Pharmaceuticals Inc., Tarrytown, New York (M.C.); and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Princeton, New Jersey (K.D.).
Publikováno v: Drug metabolism and disposition: the biological fate of chemicals [Drug Metab Dispos] 2024 Aug 14; Vol. 52 (9), pp. 966-974. Date of Electronic Publication: 2024 Aug 14.
Zobrazit plný text záznamu
2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
3
Akademický článek
Mass Spectrometric Characterization of an Acid-Labile Adduct Formed with 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and Albumin in Humans.
Autor: Wang Y, Villalta PW, Peng L; School of Food Science and Engineering, Wuhan Polytechnic University , ChangQing Garden, Hankou, Wuhan 430023, P. R. China., Dingley K; Biosciences and Biotechnology Division, Center for Accelerator Mass Spectrometry, Lawrence Livermore National Laboratory , Livermore, California 94550, United States., Malfatti MA; Biosciences and Biotechnology Division, Center for Accelerator Mass Spectrometry, Lawrence Livermore National Laboratory , Livermore, California 94550, United States., Turteltaub KW; Biosciences and Biotechnology Division, Center for Accelerator Mass Spectrometry, Lawrence Livermore National Laboratory , Livermore, California 94550, United States., Turesky RJ
Publikováno v: Chemical research in toxicology [Chem Res Toxicol] 2017 Feb 20; Vol. 30 (2), pp. 705-714. Date of Electronic Publication: 2017 Jan 18.
Zobrazit plný text záznamu
4
Akademický článek
Investigation of piperazine benzamides as human β 3 adrenergic receptor agonists for the treatment of overactive bladder.
Autor: Harper BH; Merck & Co., Inc., 126 E. Lincoln Ave., Rahway, NJ 07065, United States. Electronic address: bart_harper@merck.com., Wang L; Merck & Co., Inc., 126 E. Lincoln Ave., Rahway, NJ 07065, United States., Zhu C; Merck & Co., Inc., 126 E. Lincoln Ave., Rahway, NJ 07065, United States., Kar NF; Merck & Co., Inc., 126 E. Lincoln Ave., Rahway, NJ 07065, United States., Li B; Merck & Co., Inc., 126 E. Lincoln Ave., Rahway, NJ 07065, United States., Moyes CR; Merck & Co., Inc., 126 E. Lincoln Ave., Rahway, NJ 07065, United States., Goble SD; Merck & Co., Inc., 126 E. Lincoln Ave., Rahway, NJ 07065, United States., Costa M; Merck & Co., Inc., 126 E. Lincoln Ave., Rahway, NJ 07065, United States., Dingley K; Merck & Co., Inc., 126 E. Lincoln Ave., Rahway, NJ 07065, United States., Di Salvo J; Merck & Co., Inc., 126 E. Lincoln Ave., Rahway, NJ 07065, United States., Ha SN; Merck & Co., Inc., 126 E. Lincoln Ave., Rahway, NJ 07065, United States., Hurley A; Merck & Co., Inc., 126 E. Lincoln Ave., Rahway, NJ 07065, United States., Li X; Merck & Co., Inc., 126 E. Lincoln Ave., Rahway, NJ 07065, United States., Miller RR; Merck & Co., Inc., 126 E. Lincoln Ave., Rahway, NJ 07065, United States., Nagabukuro H; Merck & Co., Inc., 126 E. Lincoln Ave., Rahway, NJ 07065, United States., Salituro GM; Merck & Co., Inc., 126 E. Lincoln Ave., Rahway, NJ 07065, United States., Smith S; Merck & Co., Inc., 126 E. Lincoln Ave., Rahway, NJ 07065, United States., Struthers M; Merck & Co., Inc., 126 E. Lincoln Ave., Rahway, NJ 07065, United States., Hale JJ; Merck & Co., Inc., 126 E. Lincoln Ave., Rahway, NJ 07065, United States., Edmondson SD; Merck & Co., Inc., 126 E. Lincoln Ave., Rahway, NJ 07065, United States., Berger R; Merck & Co., Inc., 126 E. Lincoln Ave., Rahway, NJ 07065, United States.
Publikováno v: Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2017 Feb 15; Vol. 27 (4), pp. 1094-1098. Date of Electronic Publication: 2016 Dec 11.
Zobrazit plný text záznamu
6
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
7
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
8
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
9
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
10
Akademický článek
Discovery and development of benzo-[1,2,4]-triazolo-[1,4]-oxazepine GPR142 agonists for the treatment of diabetes.
Autor: Wilson JE; Merck Research Laboratories, Rahway, NJ 07065, USA. Electronic address: jonathan_wilson@merck.com., Kurukulasuriya R; Merck Research Laboratories, Rahway, NJ 07065, USA., Sinz C; Merck Research Laboratories, Rahway, NJ 07065, USA., Lombardo M; Merck Research Laboratories, Rahway, NJ 07065, USA., Bender K; Merck Research Laboratories, Rahway, NJ 07065, USA., Parker D; Merck Research Laboratories, Rahway, NJ 07065, USA., Sherer EC; Merck Research Laboratories, Rahway, NJ 07065, USA., Costa M; Merck Research Laboratories, Rahway, NJ 07065, USA., Dingley K; Merck Research Laboratories, Rahway, NJ 07065, USA., Li X; Merck Research Laboratories, Rahway, NJ 07065, USA., Mitelman S; Merck Research Laboratories, Rahway, NJ 07065, USA., Tong S; Merck Research Laboratories, Rahway, NJ 07065, USA., Bugianesi R; Merck Research Laboratories, Rahway, NJ 07065, USA., Ehrhardt A; Merck Research Laboratories, Rahway, NJ 07065, USA., Priest B; Merck Research Laboratories, Rahway, NJ 07065, USA., Ratliff K; Merck Research Laboratories, Rahway, NJ 07065, USA., Ujjainwalla F; Merck Research Laboratories, Rahway, NJ 07065, USA., Nargund R; Merck Research Laboratories, Rahway, NJ 07065, USA., Hagmann WK; Merck Research Laboratories, Rahway, NJ 07065, USA., Edmondson S; Merck Research Laboratories, Rahway, NJ 07065, USA.
Publikováno v: Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2016 Jun 15; Vol. 26 (12), pp. 2947-2951.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje